The structures
of Bu-2470A, B1, B2a, and B2b have been determined. Bu-2470A is a simple octapeptide having no fatty acid moiety, while Bu-2470 B1, B2a and B2b are octapeptides that have been acylated with a ;3-hydroxy C11 or C10 fatty acid.
The octapeptide structure of Bu-2470 components was found identical with that of octapeptin C1, hence generic names of octapeptin C0, C2 C3 and C4 are proposed for Bu-2470 A, B1, B2, and B2b, respectively.
Bu-2470 is a new peptide antibiotic complex produced by a strain of Bacillus circulars. The producing organism, fermentation, isolation and properties of Bu-2470 A, B1 and B2 have been reported1).
This paper describes the structure determination of Bu-2470 A, B1, B2a and B2b.
Constituent
Amino Acids of Bu-2470 A
The amino acid analysis of the acid hydrolysate of Bu-2470 A indicated the presence of phenylalanine (Phe), leucine (Leu) and a,r-diaminobutyric acid (Dab) with a molar ratio of 1: 2: 5. The specific rotation values (in 5 N HCI) of the isolated amino acids are + 16° for Leu,-5° for Phe and +11°
for Dab, indicating that Bu-2470 A consists of two L-Leu, one D-Phe, and one D-and four L-Dab'2)
No fatty acid was detected in the hydrolysate. Thus, the amino acid composition, including number and chirarity, of Bu-2470 A and the location of two Dab constituents described above are the same as those reported for octapeptin C15).
Fatty Acid Moieties of Bu-2470 B1 and B2
Bu-2470 B1 and B2 were heated with 6 N HCl for 16 hours. The amino acid analysis of the hydrolysate showed that the amino acid constituents of Bu-2470 B1 and B2 are same as those of Bu-2470 A. In addition, the presence of a lipophilic acidic substance was indicated in the hydrolysate of Bu-2470 B1 and B2.
Thus, Bu-2470 B1 was briefly hydrolyzed with 6 N HCl for 30 minutes and the hydrolyzate was extracted with diethyl ether. Evaporation of the etherial extract afforded a fatty acid which was identified as 3-hydroxy-8-methyldecanoic acid by the GC-MS analysis of its methyl ester. In a similar manner, the hydrolysate of Bu-2470 B2 yielded two fatty acids, which were identified as 3-hydroxy-8-methylnonanoic acid and 3-hydroxydecanoic acid. Authentic samples of these fatty acids were obtained from the acid hydrolysate of Bu-18808) and antibiotic EM-49 complex'). Bu-2470 B2 was therefore shown to be comprised of two subcomponents having different fatty acid moieties. The two subcomponents were designated as Bu-2470 B2a (which contains 3-hydroxy-8-methylnonanoic acid) and Bu-2470 B2b (which contains 3-hydroxydecanoic acid).
Enzymatic Deacylation of Bu-2470 B and Octapeptins
KIMURA and HIRAM reported that cells of Pseudomonas sp. strain M-6-3 possessed an enzymatic activity that deacylates polymyxins and the enzyme was named polymyxin acylase5). A strain of P. EM-49 complex" and octapeptin C1 (antibiotic 333-25)11) were also treated with the polymyxin acylase at 37°C for 5 days affording their deacylation products. assigned for Bu-2470 A, 131, B., and 132b.
Discussion
The class name of "octapeptin" has been proposed" for a group of octapeptide antibiotics acylated with a fatty acid residue. EM-49 a and ;3 are now designated as octapeptins A,-A,, which contain no phenylalanine (Phe) in the peptide structure. EM-49) and 5, having one L-Phe, are renamed octapeptins B1 ~ B3. Octapeptin C1 is a synonym for antibiotic 333-25, which contain D-Phe as a structural element. The peptide structure of Bu-2470 components is the same as that of octapeptin C1. Since Bu-2470 B1, B20 and BZb differ from octapeptin C1 only in the fatty acid moiety, they are designated as octapeptin C2, C3 and C" respectively. Bu-2470 A has a non-acylated octapeptide structure, which is the first such occurrence in the octapeptin group of antibiotics. It is proposed to extend the original nomenclature system to include non-acylated octapeptide antibiotics by placing subscript number "0" after the letter. Thus, Bu-2470 A can be called octapeptin Co.
Experimental

Hydrolysis of Bu-2470 A
A solution of Bu-2470 A (300 mg) in 15 ml of 6 N HCI was heated at 105°C for 15 hours in a sealed tube. The reaction mixture was concentrated in vacuo to dryness. The residue was dissolved in 1 ml of water and chromatographed on a column of Dowex 50WX4 (12 x 250 mm). The column was developed with increasing concentration of hydrochloric acid (0.1 N -1.0 N), the elution being monitored by ninhydrin test and TLC (system A-107*). The appropriate fractions were collected and concentrated in vacno to yield the following 3 amino acids: Preparation and Acid Hydrolysis of Penta-(2,4-dinitrophenyl)-Bu-2470 A A solution of dinitrofluorobenzene (236 mg) in 2 ml of ethanol was added to an aqueous solution (4 ml) of Bu-2470 A (100 mg) and NaHCO3 (134 mg), and the mixture was stirred for 1.5 hours at 20°C in a dark room. Yellow solid precipitated was collected by filtration, washed with water and benzene, and then dried in vacuo. The crude product was purified by silica gel chromatography.
The column (10 x 200 mm) was eluted with CHCl3 -MeOH (93: 7) and the elution was monitored by the characteristic yellow color and TLC. The appropriate fractions were collected and evaporated in vacuo to give 111 mg of the DNP derivative of Bu-2470 A. 2,,,,,, in 1.0 % dioxane -MeOH : 247 nm (E, ;,, 472). TLC (SD-105*): Rf 0.43.
A sample of DNP-Bu-2470 A (5 mg) was heated at 105°C with 0.5 ml of 6 N HC1 in a sealed tube for 15 hours. The reaction mixture was concentrated in vacuo and lyophilized. The yellow solid thus obtained was analyzed by TLC and the following five compounds were identified: Isolation of Fatty Acids from Bu-2470 B1 and B2, Bu-1880 and EM-49 A solution of Bu-2470 B1 (10 mg) in 0.5 ml of 6 N HCl was heated at 105°C for 0.5 hour in a sealed tube. The hydrolysate was added with 5 ml of water and extracted with two 5-ml portions of diethyl ether. The ethereal solution was dried over anhydrous Na2SO, and concentrated in vacuo to give an oily residue (2 mg). The oil was taken into 3 ml of ether and treated with an excess of diazomethane in ethereal solution. Evaporation of the solvent gave the methyl ester (2 mg) which was analyzed by gas chromatography (GC; Shimadzu GC-4BPT) and GC-mass spectrometry (GC-MS; Shimadzu LKB-9000). In the same manner, Bu-2470 B2 (10 mg), Bu-1880 (10 mg) and EM-49 (10 mg) were hydrolyzed and the fatty acid moieties converted to methyl esters. The GC and GC-MS analysis of these methyl esters are shown below: .0) was combined with polymyxin acylase (120 mg) and the mixture incubated at 37°C with shaking for 3 days. The enzymatic reaction mixture was centrifuged, and the clear supernatant was adjusted to pH 2.0 and extracted with two 20-ml portions of 1-butanol. Evaporation of the extract yielded 26 mg of unchanged Bu-2470 B. The aqueous layer was adjusted to pH 9.5 with 2 N NH4OH and extracted again with two 20-m1 aliquots of 1-butanol. Second butanol extracts were combined and concentrated in vacuo to afford the crude solid of deacyl Bu-2470 B (55 mg). The solid was dissolved in 2 ml of water, adjusted to pH 2.0 with 1 N HC1 and chromatographed on a column of Diaion HP-20 (10 x 160 mm). The column was developed with water and the fractions were monitored by ninhydrin assay and TLC (system S-118*). The yield of deacyl Bu-2470 B was 32 mg.
By essentially the same procedure as described in the above experiment, EM-49 complex (10 mg) was treated with polymyxin acylase (12 mg) affording 5.0 mg of deacyl EM-49 along with 1.5 mg of EM-49 recovered. Similarly, deacylation of octapeptin C1 (10 mg) with polymyxin acylase (12 mg) yielded 4.9 mg of deacyloctapeptin C1 and 2.5 mg of unchanged octapeptin C1.
